Prof. Dr. med. Damian Wild

Frey, Simon M., Schneider, Igor, Otto, Ann-Sophie, Geiser, Florian, Wild, Damian, Haaf, Philip, Mahfoud, Felix, Mueller, Christian, & Zellweger, Michael J. (2025). Evaluation of the 2024 European Society of Cardiology risk-factor and calcium score-weighted clinical likelihoods as gatekeeper for patients with suspected chronic coronary syndrome referred for PET (Patent No. Suppl. 1). European Heart Journal, 46(Suppl. 1), Article Suppl. 1. https://doi.org/10.1093/eurheartj/ehaf784.307

Frey, Simon M., Schneider, Igor, Otto, Ann-Sophie, Geiser, Florian, Wild, Damian, Tsirkin, Andrew, Gyoergy, Caroline, Ruff, Peter, Haaf, Philip, Mahfoud, Felix, Mueller, Christian, & Zellweger, Michael J. (2025). Comparison of the 2024 ESC risk-factor clinical likelihood model and an artificial intelligence-based tool for ischemia detection in patients with suspected chronic coronary syndrome referred for PET (Patent No. Suppl. 1). European Heart Journal, 46(Suppl. 1), Article Suppl. 1. https://doi.org/10.1093/eurheartj/ehaf784.1692

Schneider, Igor, Frey Simon M., Otto, Ann-Sophie, Geiser, Florian, Wild, Damian, Haaf, Philip, Mahfoud, Felix, & Zellweger, Michael J. (2025). Temporal trends of normal scan results and pretest probability in myocardial perfusion imaging in a tertiary referral center in Switzerland between 2000 and 2023 (Patent No. Suppl. 1). European Heart Journal, 46(Suppl. 1), Article Suppl. 1. https://doi.org/10.1093/eurheartj/ehaf784.301

Hepprich, Matthias, Romberg, Christina, Mudry, Jonathan, Refardt, Julie, Wild, Damian, Antwi, Kwadwo, & Christ, Emanuel. (2025). Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study. European Journal of Endocrinology, 193(2), 247–254. https://doi.org/10.1093/ejendo/lvaf153

Chirindel, Alin, Nicolas, Guillaume P., Westerbergh, Frida, McDougall, Lisa, Schmid, David E., Geistlich, Susanne, Tschan, Viviane J., Busslinger, Sarah D., Fokkema, Angelique, Aceto, Nicola, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Wild, Damian, & Schibli, Roger. (2025). First-in-human administration of [161Tb]Tb-SibuDAB and comparative dosimetry with standard [177Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia study. European Journal of Nuclear Medicine and Molecular Imaging, 52(5), 1628–1630. https://doi.org/10.1007/s00259-024-07009-w

Frey, Simon M, Huré, Gabrielle, Leibfarth, Jan-Philipp, Thommen, Kathrin, Amrein, Melissa L, Schaefer, Ibrahim, Rumora, Klara, Schneider, Igor G, Caobelli, Federico, Wild, Damian, Haaf, Philip, Mahfoud, Felix, Müller, Christian, & Zellweger, Michael J. (2025). Evaluation of three diagnostic algorithms to reduce normal scan rates, radiation exposure and costs in patients with suspected chronic coronary syndrome referred for 82Rb-Positron Emission Tomography (82 Rb-PET). Open Heart, 12(1). https://doi.org/10.1136/openhrt-2024-003086

Boss, Marti, Eriksson, Olof, Mikkola, Kirsi, Eek, Annemarie, Brom, Maarten, Buitinga, Mijke, Brouwers, Adrienne H., Velikyan, Irina, Waser, Beatrice, Kauhanen, Saila, Solin, Olof, Marciniak, Camille, Eriksson, Barbro, Reubi, Jean-Claude, Aveline, Cyrielle, Wild, Damian, Pattou, Francois, Talbot, Jean-Noel, Hofland, Johannes, et al. (2024). Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT. Journal of Nuclear Medicine, 65(12), 1959–1964. https://doi.org/10.2967/jnumed.124.268158

Erdil, Ertunc, Becker, Anton S., Schwyzer, Moritz, Martinez-Tellez, Borja, Ruiz, Jonatan R., Sartoretti, Thomas, Vargas, H. Alberto, Burger, A. Irene, Chirindel, Alin, Wild, Damian, Zamboni, Nicola, Deplancke, Bart, Gardeux, Vincent, Maushart, Claudia Irene, Betz, Matthias Johannes, Wolfrum, Christian, & Konukoglu, Ender. (2024). Correction to: Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks (Nature Communications, (2024), 15, 1, (8402), 10.1038/s41467-024-52622-w). Nature Communications, 15. https://doi.org/10.1038/s41467-024-54209-x

Erdil, Ertunc, Becker, Anton S., Schwyzer, Moritz, Martinez-Tellez, Borja, Ruiz, Jonatan R., Sartoretti, Thomas, Vargas, H. Alberto, Burger, A. Irene, Chirindel, Alin, Wild, Damian, Zamboni, Nicola, Deplancke, Bart, Gardeux, Vincent, Maushart, Claudia Irene, Betz, Matthias Johannes, Wolfrum, Christian, & Konukoglu, Ender. (2024). Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks. Nature Communications, 15. https://doi.org/10.1038/s41467-024-52622-w

Rottenburger, Christof, Hentschel, Michael, Fürstner, Markus, McDougall, Lisa, Kottoros, Danijela, Kaul, Felix, Mansi, Rosalba, Fani, Melpomeni, Vija, A. Hans, Schibli, Roger, Geistlich, Susanne, Behe, Martin, Christ, Emanuel R., & Wild, Damian. (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI Research, 14(1). https://doi.org/10.1186/s13550-024-01101-w

Wang, Tongtong, Sharma, Anand Kumar, Wu, Chunyan, Maushart, Claudia Irene, Ghosh, Adhideb, Yang, Wu, Stefanicka, Patrik, Kovanicova, Zuzana, Ukropec, Jozef, Zhang, Jing, Arnold, Myrtha, Klug, Manuel, De Bock, Katrien, Schneider, Ulrich, Popescu, Cristina, Zheng, Bo, Ding, Lianggong, Long, Fen, Dewal, Revati Sumukh, et al. (2024). Single-nucleus transcriptomics identifies separate classes of UCP1 and futile cycle adipocytes [Journal-article]. Cell Metabolism, 36(9), 2130–2145. https://doi.org/10.1016/j.cmet.2024.07.005

Doncic, Nikola, Zech, Christoph J., Wild, Damian, Bachmann, Helga, Mallaev, Makhmudbek, Tsvetkov, Nikolay, Hojski, Aljaz, Takes, Martin T. L., & Lardinois, Didier. (2024). CT-guided percutaneous marking of small pulmonary nodules with [99mTc]Tc-Macrosalb is very accurate and allows minimally invasive lung-sparing resection: a single-centre quality control. European Journal of Nuclear Medicine and Molecular Imaging, 51(10), 2980–2987. https://doi.org/10.1007/s00259-023-06410-1

Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, Christ, Emanuel, Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & Wild, Damian. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging, 51(8), 2517–2519. https://doi.org/10.1007/s00259-024-06641-w

Schürrle, Seval Beykan, Eberlein, Uta, Ansquer, Catherine, Beauregard, Jean-Mathieu, Durand-Gasselin, Lucie, Grønbæk, Henning, Haug, Alexander, Hicks, Rodney J., Lenzo, Nat P., Navalkissoor, Shaunak, Nicolas, Guillaume P., Pais, Ben, Volteau, Magali, Wild, Damian, McEwan, Alexander, & Lassmann, Michael. (2024). Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging, 51(8), 2428–2441. https://doi.org/10.1007/s00259-024-06682-1

Beck, Julia, Siebenhüner, Alexander, Wild, Damian, Christ, Emanuel, & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms. Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/erc-23-0235

Neubauer, Moritz C., Nicolas, Guillaume P., Bauman, Andreas, Fani, Melpomeni, Nitzsche, Egbert, Afshar-Oromieh, Ali, Forrer, Flavio, Rentsch, Cyril, Stenner, Frank, Templeton, Arnoud, Schäfer, Niklaus, Wild, Damian, & Chirindel, Alin. (2024). Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study. European Journal of Nuclear Medicine and Molecular Imaging, 51(4), 1185–1193. https://doi.org/10.1007/s00259-023-06536-2

Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, Christ, Emanuel, & Wild, Damian. (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis. Journal of Nuclear Medicine, 65(2), 228–235. https://doi.org/10.2967/jnumed.123.265894

Ivanova, Vanesa-Sindi, Davies, John, Menter, Thomas, Wild, Damian, Müller, Anne, Krasniqi, Fatime, Stenner, Frank, Papachristofilou, Alexandros, Dirnhofer, Stefan, & Tzankov, Alexandar. (2024). Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis. Histopathology, 84(3), 525–538. https://doi.org/10.1111/his.15096

Eigler, Christopher, McDougall, Lisa, Bauman, Andreas, Bernhardt, Peter, Hentschel, Michael, Blackham, Kristine A., Nicolas, Guillaume, Fani, Melpomeni, Wild, Damian, & Cordier, Dominik. (2024). Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study. Journal of Nuclear Medicine, 65(4), 573–579. https://doi.org/10.2967/jnumed.123.266817

Frey, Simon M., Huré, Gabrielle, Leibfarth, Jan-Philipp, Thommen, Kathrin, Amrein, Melissa, Rumora, Klara, Schäfer, Ibrahim, Caobelli, Federico, Wild, Damian, Haaf, Philip, Mueller, Christian E., & Zellweger, Michael J. (2024). Diagnostic utility of coronary artery calcium score percentiles and categories to exclude abnormal scans and relevant ischemia in rubidium positron emission tomography. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1467916

Rottenburger, Christof, Hentschel, Michael, McDougall, Lisa, Kaul, Felix, Mansi, Rosalba, Fani, Melpomeni, Vija, Alexander Hans, Schibli, Roger, Geistlich, Susanne, Behe, Martin, Christ, Emanuel Remigius, & Wild, Damian. (2024). Results of the phase I “Lumed “ study: Dose escalation of 177Lu-PP-F11N in patients with medullary thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI), 51, S202. https://doi.org/10.1007/s00259-024-06838-z

Wild, Damian, Grønbæk, Henning, Navalkissoor, Shaunak, Haug, Alexander, Nicolas, Guillaume P., Pais, Ben, Ansquer, Catherine, Beauregard, Jean-Mathieu, McEwan, Alexander, Lassmann, Michael, Pennestri, Daniele, Volteau, Magali, Lenzo, Nat P., & Hicks, Rodney J. (2023). A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging, 51(1), 183–195. https://doi.org/10.1007/s00259-023-06383-1

Mallaev, Makhmudbek, Chirindel, Alin-Florin, Lardinois, Didier, Tamm, Michael, Vija, Alexander Hans, Cachovan, Michal, Wild, Damian, Stolz, Daiana, & Nicolas, Guillaume P. (2023). 3D-Quantitated Single Photon Emission Computed Tomography/Computed Tomography: Impact on intended Management Compared to Lung Perfusion Scan in Marginal Candidates for Pulmonary Resection [Journal-article]. Clinical Lung Cancer, 24(7), 621–630. https://doi.org/10.1016/j.cllc.2023.07.006

Maushart, Claudia Irene, Sun, Wenfei, Othman, Alaa, Ghosh, Adhideb, Senn, Jaël Rut, Fischer, Jonas Gabriel William, Madoerin, Philipp, Loeliger, Rahel Catherina, Benz, Robyn Melanie, Takes, Martin, Zech, Christoph Johannes, Chirindel, Alin, Beuschlein, Felix, Reincke, Martin, Wild, Damian, Bieri, Oliver, Zamboni, Nicola, Wolfrum, Christian, & Betz, Matthias Johannes. (2023). Effect of high-dose glucocorticoid treatment on human brown adipose tissue activity: a randomised, double-blinded, placebo-controlled cross-over trial in healthy men. eBioMedicine, 96. https://doi.org/10.1016/j.ebiom.2023.104771

Schmidlin, Moira, Sadowski, Samira M., Siebenhüner, Alexander, Wild, Damian, Christ, Emanuel, & Refardt, Julie. (2023). Improvement of Lung NET Management through Standardized Care—A Swiss Nationwide Observational Study. Cancers, 15(8). https://doi.org/10.3390/cancers15082270

Askari E, Moghadam SZ, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CM, Alexander Walter M, Capoccetti F, Kasi PM, & Strosberg J. (2023). Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review. Journal of Nuclear Medicine Technology, 51(1), 22–25. https://doi.org/10.2967/jnmt.122.264904

Sira, Lívia, Zsíros, Noémi, Bidiga, László, Barna, Sándor, Kanyári, Zsolt, Nagy, Edit B., Guillaume, Nicolas, Wild, Damian, Rázsó, Katalin, Andó, Szilvia, Balogh, István, Nagy, Endre V., & Balogh, Zoltán. (2023). Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1095815

Wild, Damian, & Fani, Melpomeni. (2023). Case Study #6: [177 Lu]Lu-DOTA-JR11: A Somatostatin Receptor Subtype 2 Antagonist for Radiopharmaceutical Therapy. In Radiopharmaceutical Therapy (pp. 335–348). Springer International Publishing. https://doi.org/10.1007/978-3-031-39005-0_16

Varum F, Thorne H, Bravo R, Gilgen D, Hartig C, Nicolas GP, Wild D, Liakoni E, & Haschke M. (2022). Targeted colonic release formulations of mesalazine – A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis. International Journal of Pharmaceutics, 625, 122055. https://doi.org/10.1016/j.ijpharm.2022.122055

Hasegawa S., Kobayashi N., Wild D., Kaul F., Okubo N., Suzuki A., Kurita Y., Takano S., Nakajima A., & Ichikawa Y. (2022). Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors. Cancers, 14(14). https://doi.org/10.3390/cancers14143317

Refardt J, Hofland J, Wild D., & Christ E. (2022). Molecular Imaging of Neuroendocrine Neoplasms. Journal of Clinical Endocrinology and Metabolism, 107(7), E2662–E2670. https://doi.org/10.1210/clinem/dgac207

Christ E, Wild D, & Refardt J. (2022). Molecular Imaging in neuroendocrine neoplasias. Presse Medicale, 51(2), 104115. https://doi.org/10.1016/j.lpm.2022.104115

Freitag MT, Bremerich J, Wild D, Haaf P, Zellweger MJ, & Caobelli F. (2022). Quantitative myocardial perfusion 82Rb-PET assessed by hybrid PET/coronary-CT: Normal values and diagnostic performance. Journal of Nuclear Cardiology, 29(2), 464–473. https://doi.org/10.1007/s12350-020-02264-4

Fani, Melpomeni, Mansi, Rosalba, Nicolas, Guillaume P., & Wild, Damian. (2022). Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals. Cancers, 14(5). https://doi.org/10.3390/cancers14051172

Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, Koumarianou A, Krenning EP, Raymond E, Bodei L, Sorbye H, Welin S, Wiedenmann B, Wild D, Howe JR, Yao J, O’Toole D, Sundin A, & Prasad V. (2022). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of Neuroendocrinology, 34(3), e13040. https://doi.org/10.1111/jne.13040

Hayes AR, Crawford A, Al Riyami K, Tang C, Bomanji J, Baldeweg SE, Wild D, Morganstein D, Harry A, Grozinsky-Glasberg S, Oleinikov K, Khoo B, Caplin ME, Nicolas GP, & Grossman AB. (2021). Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy. Journal of Clinical Endocrinology and Metabolism, 106(12), E4903–E4916. https://doi.org/10.1210/clinem/dgab588

Refardt J, Hofland J, Wild D, & Christ E. (2021). New Directions in Imaging Neuroendocrine Neoplasms. Current Oncology Reports, 23(12), 143. https://doi.org/10.1007/s11912-021-01139-2

Theiler D., Cattaneo M, Dierickx L.O., Igaz P., Grozinsky-Glasberg S, Bournaud C., O’dorisio T., Sue O’Dorisio M., Wild D., Christ E., & Nicolas GP. (2021). Safety and efficacy of peptide-receptor radionuclide therapy in elderly neuroendocrine tumor patients. Cancers, 13(24). https://doi.org/10.3390/cancers13246290

Kobayashi N, Wild D, Kaul F, Shimamura T, Takano S, Takeda Y, Okubo N, Suzuki A, Tokuhisa M, & Ichikawa Y. (2021). Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors. Journal of Hepato-Biliary-Pancreatic Sciences, 28(9), 727–739. https://doi.org/10.1002/jhbp.1014

Refardt J, Hofland J, Kwadwo A, Nicolas GP, Rottenburger C, Fani M, Wild D, & Christ E. (2021). Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges. Reviews in Endocrine and Metabolic Disorders, 22(3), 581–594. https://doi.org/10.1007/s11154-020-09552-x

Wild D, Antwi K, Fani M, & Christ ER. (2021). Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic? Journal of Nuclear Medicine, 62(Suppl 2), 44S–50S. https://doi.org/10.2967/jnumed.120.246009

Antwi K, Wiesner P., Merkle E.M., Zech CJ, Boll DT, Wild D, Christ E, & Heye T. (2021). Research article investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI. PLoS ONE, 16(6 June 2021), e0253078. https://doi.org/10.1371/journal.pone.0253078

Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kabasakal L, Kaltsas G, Lewington V, Minozzi S, Cinquini M, Öberg K, et al. (2021). Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. European Journal of Cancer, 146, 56–73. https://doi.org/10.1016/j.ejca.2021.01.008

Braun M, Cachovan M, Kaul F, Caobelli F, Bäumer M, Hans Vija A, Pagenstert G, Wild D, & Kretzschmar M. (2021). Accuracy comparison of various quantitative [99mTc]Tc-DPD SPECT/CT reconstruction techniques in patients with symptomatic hip and knee joint prostheses. EJNMMI Research, 11(1), 60. https://doi.org/10.1186/s13550-021-00794-7

Preisig, Daniel, Varum, Felipe, Bravo, Roberto, Hartig, Claudia, Spleiss, Johannes, Abbes, Sonia, Caobelli, Federico, Wild, Damian, Puchkov, Maxim, Huwyler, Jörg, & Haschke, Manuel. (2021). Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: a clinical pharmacoscintigraphy study. European Journal of Pharmaceutics and Biopharmaceutics, 165, 22–30. https://doi.org/10.1016/j.ejpb.2021.05.002

Schaerli N, Abächerli R, Walter J, Honegger U, Puelacher C, Rinderknecht T, Müller D, Boeddinghaus J, Nestelberger T, Strebel I, Badertscher P, Badertscher P, du Fay de Lavallaz J, Twerenbold R, Wussler D, Hofer J, Leber R, Kaiser C, Osswald S, et al. (2020). Incremental value of high-frequency QRS analysis for diagnosis and prognosis in suspected exercise-induced myocardial ischaemia. European Heart Journal: Acute Cardiovascular Care, 9(8), 836–847. https://doi.org/10.1177/2048872619842988

Häfliger S, Seidel AK, Schoch E, Reichmann J, Wild D, Steinmann-Schwager S, & Pless M. (2020). Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor (Patent No. 3). Case Reports in Oncology, 13(3), Article 3. https://doi.org/10.1159/000510334

Caobelli F, Braun M, Haaf P, Wild D, & Zellweger MJ. (2020). Quantitative 99mTc-DPD SPECT/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores. Journal of Nuclear Cardiology, 27(5), 1456–1463. https://doi.org/10.1007/s12350-019-01893-8

Antwi K, Hepprich M, Müller NA, Reubi JC, Fani M, Rottenburger C, Nicolas G, Kaul F, Christ ER, & Wild D. (2020). Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging. Clinical Nuclear Medicine, 45(9), E386–E392. https://doi.org/10.1097/rlu.0000000000003124

Rottenburger C, Nicolas GP, McDougall L, Kaul F, Cachovan M, Vija AH, Schibli R, Geistlich S, Schumann A, Rau T, Glatz K, Behe M, Christ ER, & Wild D. (2020). Cholecystokinin 2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma: Results of the lumed phase 0a study. Journal of Nuclear Medicine, 61(4), 520–523. https://doi.org/10.2967/jnumed.119.233031

Christ E, Antwi K, Fani M, & Wild D. (2020). Innovative imaging of insulinoma: The end of sampling? a review. Endocrine-Related Cancer, 27(4), R79–R92. https://doi.org/10.1530/erc-19-0476

Fischer JGW, Maushart CI, Becker AS, Müller J, Madoerin P, Chirindel A, Wild D, Ter Voert EEGW, Bieri O, Burger I, & Betz MJ. (2020). Comparison of [18F]FDG PET/CT with magnetic resonance imaging for the assessment of human brown adipose tissue activity. EJNMMI Research, 10(1), 85. https://doi.org/10.1186/s13550-020-00665-7

Hepprich M, Antwi K, Waser B, Reubi JC, Wild D, Christ ER, & Christ ER. (2020). Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging [Hindawi Limited]. Case Reports in Endocrinology, 2020, 4510910. https://doi.org/10.1155/2020/4510910

Antwi K, Nicolas G, Fani M, Heye T, Pattou F, Grossman A, Chanson P, Reubi JC, Perren A, Gloor B, Vogt DR, Wild D, & Christ E. (2019). Ga-Exendin-4 PET/CT Detects Insulinomas in Patients with Endogenous Hyperinsulinemic Hypoglycemia in MEN-1. Journal of Clinical Endocrinology and Metabolism, 104(12), 5843–5852. https://doi.org/10.1210/jc.2018-02754

Buitinga M, Jansen T, van der Kroon I, Woliner-van der Weg W, Boss M, Janssen M, Aarntzen E, Béhé M, Wild D, Visser E, Brom M, & Gotthardt M. (2019). Succinylated gelatin improves the theranostic potential of radiolabeled exendin-4 in insulinoma patients. Journal of Nuclear Medicine, 60(6), 812–816. https://doi.org/10.2967/jnumed.118.219980

Wolf KI, Jha A, van Berkel A, Wild D, Janssen I, Millo CM, Janssen MJR, Gonzales MK, Timmers HJKM, & Pacak K. (2019). Eruption of Metastatic Paraganglioma After Successful Therapy with 177Lu/90Y-DOTATOC and 177Lu-DOTATATE (Patent No. 3). Nuclear Medicine and Molecular Imaging, 53(3), Article 3. https://doi.org/10.1007/s13139-019-00579-w

Antwi K, Nicolas G, Fani M, Christ E, & Wild D. (2019). Volume Replacement Fluid Demarks Benign Insulinoma with 68Ga-DOTA-Exendin-4 PET/CT. Clinical Nuclear Medicine, 44(5), E347–E348. https://doi.org/10.1097/rlu.0000000000002522

Antwi K, Nicolas G, Wild D, & Christ E. (2019). Molecular imaging for neuroendocrine tumours. Swiss Medical Weekly, 149(9-10), w20017. https://doi.org/10.4414/smw.2019.20017

Beykan S, Fani M, Jensen SB, Nicolas G, Wild D, Kaufmann J, & Lassmann M. (2019). In vivo biokinetics of 177Lu-OPS201 in mice and pigs as a model for predicting human dosimetry. Contrast Media and Molecular Imaging, 2019, 6438196. https://doi.org/10.1155/2019/6438196

Honegger, Ursina, Walter, Joan E., Mueller, Deborah, Puelacher, Christian, Schaerli, Nicolas, Twerenbold, Raphael, Badertscher, Patrick, Boeddinghaus, Jasper, Nestelberger, Thomas, du Fay de Lavallaz, Jeanne, Wussler, Desiree, Pfister, Otmar, Jeger, Raban, Kaiser, Christoph, Wild, Damian, Schmidt-Trucksäss, Arno, Reichlin, Tobias, & Mueller, Christian. (2019). Prevalence and determinants of exercise-induced left ventricular dysfunction in patients with coronary artery disease. European Journal of Clinical Investigation, 49(6), e13112. https://doi.org/10.1111/eci.13112

Sauter AW, Mansi R, Hassiepen U, Muller L, Panigada T, Wiehr S, Wild AM, Geistlich S, Béhé M, Rottenburger C, Wild D, & Fani M. (2019). Targeting of the cholecystokinin-2 receptor with the minigastrin analog 177 Lu-DOTA-PP-F11N: Does the use of protease inhibitors further improve in vivo distribution? Journal of Nuclear Medicine, 60(3), 393–399. https://doi.org/10.2967/jnumed.118.207845

Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B, Christ E, & Wild D. (2018). Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2318–2327. https://doi.org/10.1007/s00259-018-4101-5

Valente LG, Antwi K, Nicolas GP, Wild D, & Christ E. (2018). Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycaemia: A neurological chameleon (observational study). Swiss Medical Weekly, 148(45-46), w14682. https://doi.org/10.4414/smw.2018.14682

Omlin, Aurelius, Spahn, Martin, Beyer, Jörg, Eberli, Daniel, Gillessen, Silke, Jochum, Wolfram, Kueng, Marc, Nitzsche, Egbert, Rentsch, Cyrill A, Roggero, Enrico, Schmid, Hans-Peter, Stenner, Frank, Templeton, Arnoud J, Templeton, Arnoud J, Wild, Damian, Wyler, Stephen, Zwahlen, Daniel, & Cathomas, Richard. (2018). [Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]. Praxis, 107(19), 1043–1051. https://doi.org/10.1024/1661-8157/a003054

Nicolas GP, Beykan S, Bouterfa H, Kaufmann J, Bauman A, Lassmann M, Reubi JC, Rivier JEF, Maecke HR, Fani M, & Wild D. (2018). Safety, biodistribution, and radiation dosimetry of 68 Ga-OPS202 in patients with gastroenteropancreatic neuroendocrine tumors: A prospective phase I imaging study. Journal of Nuclear Medicine, 59(6), 909–914. https://doi.org/10.2967/jnumed.117.199737

Nicolas GP, Schreiter N, Kaul F, Uiters J, Bouterfa H, Kaufmann J, Erlanger TE, Cathomas R, Christ E, Fani M, & Wild D. (2018). Sensitivity Comparison of (68)Ga-OPS202 and (68)Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 59(6), 915–921. https://doi.org/10.2967/jnumed.117.199760

Nicolas GP, Wild D, & Fani M. (2018). Reply: Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists. (Patent No. 3). 59(3), Article 3. https://doi.org/10.2967/jnumed.117.203703

Badertscher, Patrick, Strebel, Ivo, Honegger, Ursina, Schaerli, Nicolas, Müller, Deborah, Puelacher, Christian, Wagener, Max, Abächerli, Roger, Walter, Joan, Sabti, Zaid, Sazgary, Lorraine, Marbot, Stella, du Fay de Lavallaz, Jeanne, Twerenbold, Raphael, Boeddinghaus, Jasper, Nestelberger, Thomas, Kozhuharov, Nikola, Breidthardt, Tobias, Shrestha, Samyut, et al. (2018). Automatically computed ECG algorithm for the quantification of myocardial scar and the prediction of mortality. Clinical research in cardiology, 107(9), 824–835. https://doi.org/10.1007/s00392-018-1253-z

Müller, Deborah, Puelacher, Christian, Honegger, Ursina, Walter, Joan E., Badertscher, Patrick, Schaerli, Nicolas, Strebel, Ivo, Twerenbold, Raphael, Boeddinghaus, Jasper, Nestelberger, Thomas, Hollenstein, Christina, du Fay de Lavallaz, Jeanne, Jeger, Raban, Kaiser, Christoph, Wild, Damian, Rentsch, Katharina, Buser, Andreas, Zellweger, Michael, Reichlin, Tobias, & Müller, Christian. (2018). Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Approach in the Detection of Functionally Relevant Coronary Artery Disease. Clinical Chemistry, 64(11), 1596–1606. https://doi.org/10.1373/clinchem.2018.286971

Puelacher, Christian, Wagener, Max, Honegger, Ursina, Assadian, Mustafa, Schaerli, Nicolas, Mueller, Deborah, Strebel, Ivo, Twerenbold, Raphael, Boeddinghaus, Jasper, Nestelberger, Thomas, Wildi, Karin, Sabti, Zaid, Sazgary, Lorraine, Badertscher, Patrick, du Fay de Lavallaz, Jeanne, Marbot, Stella, Kaiser, Christoph, Wild, Damian, Zellweger, Michael J., et al. (2018). Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia. Clinical Biochemistry, 52, 33–40. https://doi.org/10.1016/j.clinbiochem.2017.10.014

Walter, Joan E., Honegger, Ursina, Puelacher, Christian, Müller, Deborah, Wagener, Max, Schaerli, Nicolas, Strebel, Ivo, Twerenbold, Raphael, Boeddinghaus, Jasper, Nestelberger, Thomas, Sazgary, Lorraine, Marbot, Stella, du Fay de Lavallaz, Jeanne, Kaiser, Christoph, Osswald, Stefan, Wild, Damian, Rentsch, Katharina, Zellweger, Michael, Reichlin, Tobias, & Müller, Christian. (2018). Prospective Validation of a Biomarker-Based Rule Out Strategy for Functionally Relevant Coronary Artery Disease. Clinical Chemistry, 64(2), 386–395. https://doi.org/10.1373/clinchem.2017.277210

Katona B.W., Roccaro GA, Soulen MC, Yang YX, Bennett B.J., Riff BP, Glynn RA, Wild D, Nicolas G.P., Pryma DA, Teitelbaum U.R., & Metz DC. (2017). Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis. Pancreas, 46(9), 1121–1126. https://doi.org/10.1097/MPA.0000000000000919

Fani M, Nicolas GP, & Wild D. (2017). Somatostatin receptor antagonists for imaging and therapy. Journal of Nuclear Medicine, 58(Suppl 2), 61S–66S. https://doi.org/10.2967/jnumed.116.186783

Nicolas GP, Mansi R, McDougall L, Kaufmann J, Bouterfa H, Wild D, & Fani M. (2017). Biodistribution, pharmacokinetics, and dosimetry of 177Lu-,90Y-, and 111In-labeled somatostatin receptor antagonist OPS201 in comparison to the agonist 177Lu-DOTATATE: The mass effect. Journal of Nuclear Medicine, 58(9), 1435–1441. https://doi.org/10.2967/jnumed.117.191684

Puelacher C, Wagener M, Abächerli R, Honegger U, Lhasam N, Schaerli N, Prêtre G, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Rubini Giménez M, Hillinger P, Wildi K, Sabti Z, Badertscher P, Cupa J, Kozhuharov N, du Fay de Lavallaz J, et al. (2017). Diagnostic value of ST-segment deviations during cardiac exercise stress testing: Systematic comparison of different ECG leads and time-points. International Journal of Cardiology, 238, 166–172. https://doi.org/10.1016/j.ijcard.2017.02.079

Wan MYS, Endozo R, Michopoulou S, Shortman R, Rodriguez-Justo M, Menezes L, Yusuf S, Richards T, Wild D, Waser B, Reubi JC, & Groves A. (2017). PET/CT imaging of unstable carotid plaque with 68Ga-labeled somatostatin receptor ligand. Journal of Nuclear Medicine, 58(5), 774–780. https://doi.org/10.2967/jnumed.116.181438

Wagener M, Abächerli R, Honegger U, Schaerli N, Prêtre G, Twerenbold R, Puelacher C, Sunier G, Reddiess P, Rubini Gimenez M, Wildi K, Boeddinghaus J, Nestelberger T, Badertscher P, Sabti Z, Schmid R, Leber R, Widmer DF, Shrestha S, et al. (2017). Diagnostic and Prognostic Value of Lead aVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia. American Journal of Cardiology, 119(7), 959–966. https://doi.org/10.1016/j.amjcard.2016.11.056

Sauter AW, Stieltjes B, Weikert T, Gatidis S, Wiese M, Klarhöfer M, Wild D, Lardinois D, Bremerich J, & Sommer G. (2017). The spatial relationship between apparent diffusion coefficient and standardized uptake value of 18F-fluorodeoxyglucose has a crucial influence on the numeric correlation of both parameters in PET/MRI of lung tumors. Contrast Media and Molecular Imaging, 2017, 8650853. https://doi.org/10.1155/2017/8650853

Cuthbertson DJ, Banks M, Khoo B, Antwi K, Christ E, Campbell F, Raraty M, & Wild D. (2016). Application of Ga68-DOTA-exendin-4 PET/CT to localize an occult insulinoma (Patent No. 5). Clinical Endocrinology, 84(5), Article 5. https://doi.org/10.1111/cen.12973

Breuer TG, Breuer HL, Menge BA, Giese A, Uhl W, Schmidt WE, Tannapfel A, Wild D, Nauck MA, & Meier JJ. (2016). [Recurrent hypoglycemia due to an occult insulinoma]. Der Internist, 57(4), 9–385. https://doi.org/10.1007/s00108-016-0020-3

Sou SM, Puelacher C, Twerenbold R, Wagener M, Honegger U, Reichlin T, Schaerli N, Pretre G, Abächerli R, Jaeger C, Rubini Gimenez M, Wild D, Rentsch KM, Zellweger MJ, & Mueller C. (2016). Direct comparison of cardiac troponin I and cardiac troponin T in the detection of exercise-induced myocardial ischemia. Clinical Biochemistry, 49(6), 421–432. https://doi.org/10.1016/j.clinbiochem.2015.12.005

Lee G, Twerenbold R, Tanglay Y, Reichlin T, Honegger U, Wagener M, Jaeger C, Rubini Gimenez M, Hochgruber T, Puelacher C, Radosavac M, Kreutzinger P, Stallone F, Hillinger P, Krivoshei L, Herrmann T, Mayr R, Freese M, Wild D, et al. (2016). Clinical benefit of high-sensitivity cardiac troponin i in the detection of exercise-induced myocardial ischemia. American Heart Journal, 173, 8–17. https://doi.org/10.1016/j.ahj.2015.11.010

Baumann T, Rottenburger C, Nicolas G, & Wild D. (2016). Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging. Best Practice and Research: Clinical Endocrinology and Metabolism, 30(1), 45–57. https://doi.org/10.1016/j.beem.2016.01.003

Christ,Emanuel, Wild,Damian, Antwi,Kwadwo, Waser,Beatrice, Fani,Melpomeni, Schwanda,Stefanie, Heye,Tobias, Schmid,Christoph, Baer,Hans Ulrich, Perren,Aurel, & Reubi,Jean Claude. (2015). Preoperative localization of adult nesidioblastosis using (68)Ga-DOTA-exendin-4-PET/CT. Endocrine, 50(3), 3–821.

Christ E, Wild D, Antwi K, Waser B, Fani M, Schwanda S, Heye T, Schmid C, Baer HU, Perren A, & Reubi JC. (2015). Preoperative localization of adult nesidioblastosis using 68Ga-DOTA-exendin-4-PET/CT. Endocrine, 50(3), 821–823. https://doi.org/10.1007/s12020-015-0633-7

Zürcher S, Honegger U, Wagener M, Lee G, Stallone F, Marxer T, Puelacher C, Schumacher C, Sou SM, Twerenbold R, Reichlin T, Hochgruber T, Tanglay Y, Freese M, Wild D, Rentsch K, Osswald S, Zellweger M, & Mueller C. (2015). Delayed release of brain natriuretic peptide to identify myocardial ischaemia. European Journal of Clinical Investigation, 45(11), 1175–1183. https://doi.org/10.1111/eci.12535

Maas O, Joseph GB, Sommer G, Wild D, & Kretzschmar M. (2015). Association between cartilage degeneration and subchondral bone remodeling in patients with knee osteoarthritis comparing MRI and 99mTc-DPD-SPECT/CT. Osteoarthritis and Cartilage, 23(10), 1713–1720. https://doi.org/10.1016/j.joca.2015.05.014

Antwi K, Fani M, Nicolas G, Rottenburger C, Heye T, Reubi JC, Gloor B, Christ E, & Wild D. (2015). Localization of hidden insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A pilot study. Journal of Nuclear Medicine, 56(7), 1075–1078. https://doi.org/10.2967/jnumed.115.157768

Wenning AS, Kirchner P, Antwi K, Fani M, Wild D, Christ E, & Gloor B. (2015). Preoperative Glucagon-like peptide-1 receptor imaging reduces surgical trauma and pancreatic tissue loss in insulinoma patients: A report of three cases. Patient Safety in Surgery, 9(1), 23. https://doi.org/10.1186/s13037-015-0064-7

Tanglay Y, Twerenbold R, Lee G, Wagener M, Honegger U, Puelacher C, Reichlin T, Mann S, Druey S, Hochgruber T, Zürcher S, Radosavac M, Kreutzinger P, Pretre G, Stallone F, Hillinger P, Jaeger C, Rubini Gimenez M, Freese M, et al. (2015). Incremental value of a single high-sensitivity cardiac troponin i Measurement to rule out myocardial ischemia. American Journal of Medicine, 128(6), 638–646. https://doi.org/10.1016/j.amjmed.2015.01.009

Buechel, Ronny R., Kaufmann, Beat A., Tobler, Daniel, Wild, Damian, & Zellweger, Michael J. (2015). Non-invasive nuclear myocardial perfusion imaging improves the diagnostic yield of invasive coronary angiography. European Heart Journal - Cardiovascular Imaging, 16(8), 7–842. https://doi.org/10.1093/ehjci/jev095

Riff BP, Yang YX, Soulen MC, Pryma DA, Bennett B, Wild D, Nicolas G, Teitelbaum UR, & Metz DC. (2015). Peptide receptor radionuclide therapy-induced hepatotoxicity in patients with metastatic neuroendocrine tumors. Clinical Nuclear Medicine, 40(11), 845–850. https://doi.org/10.1097/RLU.0000000000000935

Wild D, Fani M, Fischer R, Del Pozzo L, Kaul F, Krebs S, Fischer R, Rivier JE, Reubi JC, Maecke HR, & Weber WA. (2014). Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: A pilot study. Journal of Nuclear Medicine, 55(8), 1248–1252. https://doi.org/10.2967/jnumed.114.138834

Lee G, Sou SM, Twerenbold R, Reichlin T, Oshima S, Hochgruber T, Zürcher S, Matter D, Tanglay Y, Freese M, Honegger U, Wild D, Rentsch K, Osswald S, Zellweger MJ, & Mueller C. (2014). B-type natriuretic peptide and clinical judgment in the detection of exercise-induced myocardial ischemia. American Journal of Medicine, 127(5), 427–435. https://doi.org/10.1016/j.amjmed.2014.01.009

Wicki, Andreas, Wild, Damian, Prêtre, Vincent, Mansi, Rosalba, Orleth, Annette, Reubi, Jean-Claude, Rochlitz, Christoph, Mamot, Christoph, Mäcke, Helmut R, & Christofori, Gerhard. (2014). Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors. EJNMMI Research, 4(1), 9. https://doi.org/10.1186/2191-219x-4-9

Zellweger MJ, Zellweger MJ, Fahrni G, Ritter M, Jeger RV, Wild D, Buser P, Kaiser C, Osswald S, Pfisterer ME, & BASKET Investigators. (2014). Prognostic value of “routine” cardiac stress imaging 5 years after percutaneous coronary intervention: The prospective long-term observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING study. JACC: Cardiovascular Interventions, 7(6), 615–621. https://doi.org/10.1016/j.jcin.2014.01.161

Christ E, Wild,Damian, Ederer,Susanne, Béhé,Martin, Nicolas,Guillaume, Caplin,Martyn E, Brändle,Michael, Clerici,Thomas, Fischli S, Stettler,Christoph, Ell,Peter J, Seufert,Jochen, Gloor,Beat, Perren,Aurel, Reubi,Jean Claude, & Forrer F. (2013). Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: A prospective multicentre imaging study. The Lancet Diabetes and Endocrinology, 1(2), 115–122. https://doi.org/10.1016/S2213-8587(13)70049-4

Wild D, Bomanji JB, Benkert P, Maecke H, Ell PJ, Reubi JC, & Caplin ME. (2013). Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. Journal of Nuclear Medicine, 54(3), 364–372. https://doi.org/10.2967/jnumed.112.111724

Körner M, Christ E., Wild D, & Reubi JC. (2012). Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications. Frontiers in Endocrinology, 3(DEC). https://doi.org/10.3389/fendo.2012.00158

Win T, Screaton NJ, Porter J, Endozo R, Wild D, Kayani I, Dickson J, Shortman RI, Reubi JC, Ell PJ, & Groves AM. (2012). Novel positron emission tomography/computed tomography of diffuse parenchymal lung disease combining a labeled somatostatin receptor analogue and 2-deoxy-2[ 18F]fluoro-D-glucose. Molecular Imaging, 11(2), 91–98. https://doi.org/10.2310/7290.2011.00030